This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Neil Godfrey: Innovator in N-Heterocyclic Compounds
Introduction
Neil Godfrey is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of chemistry, particularly in the preparation of N-heterocyclic compounds. His work has implications for the development of selective antagonists at 'neuronal' 5-hydroxytryptamine receptors.
Latest Patents
Neil Godfrey holds a patent for a process for preparing N-heterocyclic compounds. This invention relates to a process for the preparation of compounds of general formula (I), wherein R¹ represents various groups including hydrogen atoms, alkyls, and phenyl groups. The compounds of formula (I) are recognized for their potency and selectivity in targeting specific receptors.
Career Highlights
Neil Godfrey is associated with Glaxo Group Limited, where he has been instrumental in advancing research in pharmaceutical chemistry. His innovative approach has led to the development of new compounds that have potential therapeutic applications.
Collaborations
Throughout his career, Neil has collaborated with esteemed colleagues such as Ian H Coates and James A Bell. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Neil Godfrey's contributions to the field of chemistry, particularly through his patent on N-heterocyclic compounds, highlight his role as a significant inventor. His work continues to influence advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile